Brief: Imugene Imugene Receives Vaxinia Ethics Approval In Australia
09/01/2023 01:43
Jan 9 (Reuters) - Imugene Ltd IMU.AX :
* IMUGENE RECEIVES VAXINIA ETHICS APPROVAL IN AUSTRALIA
* RECEIVED HREC APPROVAL TO COMMENCE A PHASE I CLINICAL
TRIAL OF
ITS ONCOLYTIC VIROTHERAPY CANDIDATE, VAXINIA IN AUSTRALIA
Source text for Eikon: ID:nASX46sR1H
Further company coverage: IMU.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imugene
See all newsAustralia's Imugene rises on fresh responses in blood cancer drug trial
Brief: Imugene Ltd Says Leslie Chong Resigns As CEO
Australia's Imugene loses most in over 8-years on discounted placement
Brief: Imugene To Raise A$11.12 Million Via Placement At A$0.095 Per Share
Brief: Imugene Requests Trading Halt Pending Proposed Capital Raising Announcement